Bioversys AG (BIOV) — Financial Flexibility Index
Bioversys AG (BIOV) has a Financial Flexibility Index of -0.70x as of December 2025. Free cash flow of CHF-21.73 Million (operating CF CHF-21.95 Million minus capex CHF216.00K) represents -1% of total liabilities (CHF30.82 Million). Also explore Bioversys AG net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bioversys AG Financial Flexibility Index (2024–2025)
Historical Financial Flexibility Index trend for Bioversys AG across 2 annual periods. Check Bioversys AG asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Bioversys AG (2024–2025)
Year-by-year free cash flow to debt coverage for Bioversys AG. For the full company profile including market capitalisation, see BIOV stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CHF) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.70x | CHF-21.73 Million | CHF-21.95 Million | CHF30.82 Million | ▼ -10.1% |
| 2024 | -0.64x | CHF-15.54 Million | CHF-15.57 Million | CHF24.27 Million | — |